Key Metrics
CiteScore 

5.2
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Drug Investigation
Clinical Drug Investigation Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Drug Investigation ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Drug Investigation
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review.
- 8 Aug 2026
- Clinical drug investigation
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
- 1 Aug 2026
- Clinical drug investigation
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications.
- 1 Aug 2026
- Clinical drug investigation
Ketamine and Evolving Neuroplasticity.
- 1 Aug 2026
- Clinical drug investigation
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants.
- 1 Aug 2026
- Clinical drug investigation
Deuruxolitinib: New Approval.
- 1 Aug 2026
- Clinical drug investigation
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review.
- 8 Aug 2026
- Clinical drug investigation
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
- 1 Aug 2026
- Clinical drug investigation
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications.
- 1 Aug 2026
- Clinical drug investigation
Ketamine and Evolving Neuroplasticity.
- 1 Aug 2026
- Clinical drug investigation
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants.
- 1 Aug 2026
- Clinical drug investigation
Deuruxolitinib: New Approval.
- 1 Aug 2026
- Clinical drug investigation